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Resumo
A drenagem linfática pulmonar profunda (DLPP) 
desempenha um papel importante na remoção de 
materiais estranhos, constituindo os macrófagos al-
veolares a primeira linha de defesa fagocitária, dada a 
grande afinidade para microrganismos patogénicos. 
Os Bacillus subtilis são saprófitas do tracto respiratório 
humano com ampla utilização em investigação e em 
biotecnologia.
Abstract
Lung deep lymphatic drainage (LDLD) plays an im-
portant role in the removal of foreign materials from 
lungs being alveolar macrophages the first line of 
phagocytic defence with high affinity for pathogenic 
microorganisms. Bacillus subtilis is a well-known ge-
nome-decoded saprophyte of the human respiratory 
tract used in research and in the biotechnology in-
dustry.
Nanorradiolipossomas modulados molecularmente para 
estudar a drenagem linfática pulmonar profunda
Nanoradioliposomes molecularly modulated to study the 
lung deep lymphatic drainage
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As cadeias linfáticas pulmonares profundas (CLPP) 
constituem um dos primeiros locais de disseminação 
de tumores pulmonares.
Neste trabalho pretendeu-se desenvolver e validar um 
método não invasivo para avaliar as CLPP através de 
nanorradiolipossomas aerosolisados e modulados pela 
parede do esporo do Bacillus subtilis. O objectivo fi-
nal foi produzir uma formulação de nanorradiolipos-
somas capaz de imitar a dinâmica da remoção de es-
poros pelas CLPP e simultaneamente ter propriedades 
ideais como traçador para imagiologia molecular.
Testámos sete diferentes formulações lipossómicas, 
tendo a formulação F demonstrado possuir proprie-
dades fisicoquímicas e radiofarmacêuticas que a tor-
nam o traçador ideal para imagiologia molecular in 
vivo das CLPP.
Os nanorradiolipossomas da formulação F após marca-
ção com 99mTc-HMPAO foram administrados sob a 
forma de aerossóis a 20 Sus scrofa. Visualizaram-se comu-
nicações hilares e interpulmonares nos primeiros 5 minu-
tos após a inalação, as cadeias infradiafragmáticas entre os 
10 e os 20 minutos, os gânglios da cadeia aórtica aos 20 
minutos e os da região hilar renal aos 30 minutos.
Em conclusão, o método proposto visualiza os 
gânglios linfáticos e a rede linfática pulmonar pro-
funda. A modulação dos nanorradiolipossomas per-
mite que eles atinjam órgãos ou tecidos específicos, 
conferindo-lhes importantes potencialidades no âm-
bito do diagnóstico e/ou da terapêutica.
Rev Port Pneumol 2009; XV (2): 261-293
Palavras-chave: Nanorradiolipossomas, modulação 
molecular, drenagem linfática pulmonar, imagem 
nuclear funcional.
Lung deep lymphatic chains (LDLC) constitute one 
of the first sites of lung tumours’ dissemination.
In this work we intended to develop and validate a 
non-invasive method for assessing LDLC by nanora-
dioliposomes aerosolised modulated on the Bacil-
lus subtilis spore wall. The final goal was to produce a 
nanoradioliposome formulation that can mimics the 
dynamics of preferential removal of spores by LDLD 
and present the ideal properties as a tracer for mo-
lecular imaging studies.
Seven different liposomal formulations were tested, 
and the formulation-F demonstrated physicochemi-
cal and radiopharmaceutical properties that make it 
an ideal candidate as an in vivo probe for molecular 
imaging studies of the LDLC.
Nanoradioliposomes of the formulation-F after label-
ling with 99mTc-HMPAO were administered as 
aerosols to 20 Sus scrofa. Hilar and interpulmonary 
communications were visualized in first 5 minutes 
post-inhalation, infradiaphragmatic chains between 
10 and 20 minutes, the ganglia of the aortic chain at 
20 minutes and those of the renal hilar region at 30 
minutes.
Conclusion: the proposed method enables visualiza-
tion of deep lymphatic lung network and lymph 
nodes. Besides, this technique involving the modula-
tion of nanoradioliposomes targeting specific organs 
or tissues may be an important tool for diagnostic or 
even for therapeutic purposes.
Rev Port Pneumol 2009; XV (2): 261-293
Key-words: Nanoradioliposomes, molecular modu-
lation, lung lymphatic drainage, functional nuclear 
imaging.
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Introduction
Preliminary studies carried out in mongrel 
dogs (canis familiaris), which inhaled Bacillus 
subtilis aerosols labelled with technetium-99m, 
showed not only a fast disappearance of the 
pulmonary activity but also the capacity of vi-
sualize the lung deep lymphatic network.
The impossibility to use bacilli, even sapro-
phytes, in human beings, gave us the idea of 
developing radioactive nanoliposomes with 
membranes molecularly modulated to have 
a structure similar to the wall of these ba-
cilli. This approach allowed a simulation of 
their mechanical behaviour in the pulmo-
nary lymphatic network, but without pre-
senting pathogenic effects.
The molecular composition of the Bacillus 
subtilis membrane is already known1,2,3 and 
it is possible, to anticipate the structures 
that are responsible for its dynamic beha-
viour at the alveolar-capillary membrane.
The development of nanoliposomes with 
the Bacillus subtilis membrane properties 
and the study of its behaviour in an animal 
model, after being labelled with 99mTc-HM-
PAO, with Nuclear Medicine diagnostic 
purposes, as well as the interest of the deve-
lopment of a practical and not invasive 
method of visualization of the lung deep 
lymphatic chains is of great interest in se-
veral pathologic situations of this area, and 
constitute the main subject of this work.
The molecular modulation of liposomes 
can lead to the production of cells analo-
gous, or other structures with specific pro-
perties, that allows not only the visualiza-
tion of organs or tissues by the use of 
radioactive liposomes or liposomes carriers 
of radiopharmaceuticals, but involves also a 
therapeutic perspective due to the radiation 
or pharmacological effects.
The development of liposomal structures 
with dimensions around 100 nm to which 
some molecular residues can be aggregate, 
with biochemists and biological specific 
properties, could be an important tool in 
Medicine.
Lung lymphatic system
The lung lymphatic system is of fundamen-
tal importance in the alveolar and intersti-
tial clearance, not only immediately after 
the birth and during the alveolisation, with 
the fast removal of fluids of the fetal lung, 
but also during all life long, once a great di-
versity of substance can reach the pulmo-
nary alveoli, needing to be cleared in order 
to allow an efficient gas exchange through 
the alveolar-capillary barrier4,5,6,7.
The lung lymphatics, as in another organ, 
consist in collector and capillary lymphat-
ics4,5,6,7. The lymphatic collector vessels 
show valves regularly distributed through-
out its length and are the main branches of 
pulmonary lymphatic drainage, receiving 
the lymph from the lymphatic capillaries. 
This lymph is subsequently drained in di-
rection to the lymphatic nodes of the pul-
monary hila and to the systemic circulation, 
after passed through the tracheobronchial, 
tracheal and paratracheal lymphatic nodes8. 
The lymphatic capillaries are located in the 
areas of extracellular exchanges with the 
pulmonary interstitium, allowing a conti-
nuous drainage of interstitial fluid, macro-
molecules and cells6,7.
The pulmonary lymphatics (Fig. 1) are dis-
tributed in two linked networks: the superfi-
cial pleural network, located in the sub-meso-
thelial connective tissue of the visceral pleura 
and the deep intrapulmonary network, cons-
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tituting the peribronchovascular lymphatics, 
located in the connective tissue sheets of the 
pulmonary bronchial and vascular trees6,7.
The pleural lymphatics, located inside of 
the pleural sub-mesothelial connective tis-
sue, are organized as a vessel network that 
runs on the pulmonary surface, in direction 
to pulmonary hilum where they join to the 
deep lymphatic network6,8.
The peribronchovascular lymphatics go 
around the different airway generations un-
til they reached the respiratory bronchioles, 
as well as the pulmonary arterial and venous 
vessels, being the lymphatic drainage paral-
lel to the bronchovascular system.
These two plexus that are interconnected in 
anatomic terms at hilar and pleural level, in 
functional terms must remain more or less iso-
lated, because its different valves orientation4,8.
The superficial lymphatic plexus must 
transfer the lymph from the pleura and the 
fine sub-pleural parenchyma adjacent sheet 
to the pulmonary hilum, through lung sur-
face, whereas the peribronchovascular ple-
xus drains the remained pulmonary paren-
chyma throughout the blood vessels and 
airways ramifications.
Additionally, many lymphatic capillaries are 
found in the juxta-alveolar regions (Fig. 2), 
which are contiguous to the alveolar wall, 
being separate from the alveolar lumen only 
by alveolar epithelium and support con-
junctive tissue, which are very thin and only 
contains few vessels4,6,8.
This way, the lung lymphatics are presented 
in the loose connective tissue that supports 
Fig. 2 – Image obtained by electron microscopy, that shows 
a juxta-alveolar lymphatic capillary (L) contiguous to the al-
veolar space (A). [Adapted from Leak and Ferran]
Fig. 1 – Schematic representation of pulmonary lymphatics distribution and organisation. 
[Adapted from Nagaishi and Okada]
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the more peripheral pleural cells that in-
volves the pulmonary lobes, in the interal-
veolar septa, peribronchial and perivascular 
sheets.
Theory of the method
The need lung lymphographic studies in 
man, as it happens in some obstructive lym-
phatic pathologies, has been fulfilled 
through a few radiological procedures9, 
namely through indirect lymphography.
More recently, the introduction of radioiso-
topic techniques, allowed performing indi-
rect lymphoscintigraphies with tracers ad-
ministration through intrapleural, or at 
peripheral members. These methods are in-
vasive, difficult for the patient and techni-
cally hard to perform.
Our approach was to use the dynamic and 
functional properties of the lung lymphatic 
system in order to develop a tracer that will 
be drained by lymphatics after inhalation, 
and that could be detectable externally with 
a gamma camera.
Among the several exogenous materials, the 
inactivated or analogous to pathogenic 
agents seemed to be a field to explore. Our 
first choice was the research of an airways 
saprophyte microorganism, labelling it with 
a radioactive tracer and administering it as 
an aerosol and follows its route and poste-
rior localizations.
The selection elicited the Bacillus subtilis, 
which could be used in its vegetative or spo-
rulated forms.
These two forms were labelled with 99mTc 
chelated by exametazime (HMPAO) 
(Ceretec™, G.E. Healthcare, UK) and were 
administered to dogs as aerosol. Two dogs 
had received aerosols with vegetative forms, 
and the other two aerosols with spore 
forms.
The images obtained in these 4 animals, 
revelled the existence of deep lymphatic 
drainage chains, beginning with appearance 
of lymphatic nodes located in the neck re-
gion, and inguinal level at delayed times. 
The images obtained were similar with the 
two different forms, the vegetative and spore 
forms (Fig. 3).
The utilization in humans of any forms of 
microorganisms, even saprophyte is clearly 
out of question. However, we thought that 
Fig. 3 – Images obtained after Bacillus subtilis aerosol administration, as vegetative form 
(left) and as spores (right) labelled with 99mTc-HMPAO. In each image is referred the time 
after inhalation
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the production of carriers with walls similar 
to the molecular structure of cellular mem-
branes of the bacilli, but without any com-
ponents able to induce host immune re-
sponses could be a promising field of 
research.
So, we tried to obtain a liposomic formula-
tion, which bilayer composition was such 
that simulate the dynamic behaviour of the 
Bacillus subtilis, without the disadvantages 
of these, but with the inherent advantages 
of liposomes, that are: to be inert, to have 
good tolerance and to be biodegradable.
Keeping in mind the similar in vivo beha-
viour of the two forms of bacilli, and the 
faster lymphatic drainage of the spores form 
besides its easier manipulation, the spore 
membrane was used as model of liposomes 
wall.
The Bacillus subtilis spores had a complex 
composition that can schematically be appre-
ciated in Fig. 4. Basically, the Bacillus subtilis 
spore is constituted by diverse layers of varia-
ble composition: the exospore, the dense 
outer spore coat (DSC), the internal coat 
(IC), the cortex (Cx), the germ cellular wall 
(GCW) and the cellular membrane (CM).
The exospore, that represents the most ou-
ter spore layer, is composed by proteins and 
phospholipids namely cardiolipin, which is 
also named as diphosphatidylglycerol.
The dense outer spore coat (DSC) and the 
internal coat (IC), have in its constitution 
proteins, where the polyglycine II predomi-
nates, and amino acids which the most im-
portant are the glutamic acid, the lysine and 
the serine.
In the spore cortex (Cx) the mucopeptides 
and the peptidoglycans are predominate, 
namely the N-acetyl muramic acid.
The germ cellular wall (GCW), sometimes 
designated as cortical membrane, remains 
anchored on a few places to the cortex and 
basically is constituted by mucopeptides 
whereas the cellular membrane (CM) con-
tains proteins and lipids. Among the lipids, 
there are great quantities of phospholipids, 
diglycosil diglyceride and neutral lipids. Re-
lated to the spore cellular membrane phos-
pholipids, a clear predominance of cardio-
lipin exists, besides phosphatidylglycerol, 
phosphatidylethanolamine and lipo-amino 
acids such as lysine, alanine, glycine and 
leucine1,2,3,11,12.
The study of the Bacillus subtilis spore com-
position reveals the existence of great 
amounts of cardiolipin or diphosphatidyl-
glycerol and phosphatidylglycerol that are 
negatively charged phospholipids.
The value of the negative charge on the li-
posomes surface is of critical importance, 
because the pulmonary endothelium acts as 
a positive barrier. This fact is the opposite to 
the other endothelia, and several authors, 
Fig. 4 – Chemical composition of the Bacillus subtilis spore. Exospore: proteins, phospho-
lipids (cardiolipin)
DSC and IC: proteins (polyglycine II), amino-acids (glutamic acid, lysine, serine); Cx: mucopeptides, 
peptidoglycans (N-acetyl muramic acid); GCW: mucopeptides; CM: proteins, lipids: neutral lipids, dig-
lycosil diglyceride, phospholipids (cardiolipin, phosphatidylglycerol, phosphatidylethanolamine, e lipo-
amino acids) [adapted from www.gsbs.utmb.edu/microbook/ch002.htm]
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have proven through studies performed on 
the lung lymphatic drainage, a faster lym-
phatic drainage of the anionic compounds 
than the cationic ones of comparable mo-
lecular weight13.
In order to show a similar behaviour to the 
Bacillus subtilis spores, the wall of the mod-
ulated liposome must be constituted by a 
phospholipid as a main compound associa-
ted to a negative charge phospholipid and 
residues that confers its identical specificity 
to the Bacillus.
In relation to the main phospholipid, al-
though great part of the liposomes studies 
as drug carriers uses the dipalmitoyl phos-
phatidylcholine (DPPC), our option was 
different because this phospholipid forms 
particularly unstable liposomes when in 
contact to biological fluids, releasing about 
50% of its aqueous content per hour14.
As our goal was to get stable liposomes, our 
option was the distearoylphosphatidylcho-
line (DSPC), that is a saturated phospho-
lipid with 18 carbons in the two acyl chains 
that has a phase transition temperature of 
56ºC, which makes liposomes much more 
stable15-20.
Related to the phospholipid negatively 
charged, and although cardiolipin (CP) is 
the predominant lipid of the spore coat of 
Bacillus subtilis2 its use in humans put some 
problems due to its immunogenic proper-
ties21. Therefore, we select the phosphati-
dylglycerol (PG), that also it has negative 
charge and is present in the spore coat.
Nevertheless, we made also formulations 
that contained cardiolipin, for behaviour 
comparison once it is the predominant 
phospholipid of the spore coat.
As residues, we used glutamic acid (GA), 
present in dense outer spore coat and in in-
ternal coat and N-acetyl muramic acid 
(NAMA) an aminosugar present in the pep-
tidoglycan of the spore cortex11,12.
The introduction of the cholesterol (CL) in 
the liposomal bilayer was also considered, 
due to its effect on membrane stabilisation14,22 
preventing the aggregation of the small 
DSPC vesicles during the storage at 4ºC17.
We designed and tested 7 different liposomal 
formulations with the following composition 
(in parenthesis it is the molar ratio of each 
component): Formulation A – DSPC:PG:GA 
[8:1:1]; Formulation B – DSPC:PG:NAMA 
[8:1.5:0.5]; Formulation C – DSPC: CP: 
NAMA [8:1:1]; Formulation D – DSPC: 
PG:CP [8:1:1]; Formulation E – DSPC:PG: 
CP:CL [7.5:1:1:0.5]; Formulation F – DSPC: 
PG:NAMA:CL [7.5:1.5:0.5:0.5]; Formula-
tion G – DSPC:CP: NAMA:CL [7.5:1:1: 
0.5].
These formulations were evaluated in vitro 
in order to choose the one with better be-
haviour as radioactive tracer for visualisa-
tion of the deep lymphatic lung drainage, 
after its administration as aerosols.
Materials and methods
Liposomes
Chemicals
The products used for liposome produc-
tion, i.e., distearoyl phosphatidylcholine 
(DSPC), phosphatidylglycerol (PG), N-
acetyl muramic acid, glutamic acid, cardio-
lipin, cholesterol and glutathione were ob-
tained from Sigma (St. Louis, MO, USA). 
99mTc was obtained from a commercial 
99Mo/99mTc generator (G.E. Healthcare, 
UK). Exametazime or HMPAO (Ceretec™) 
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was purchased from G.E. Healthcare (UK). 
Sephadex G-25 was obtained from Pharma-
cia (Upsala, Sweden). Azoperone (Yanssen 
Pharmaceutical, Belgium) and Ketalar™ 
(Parke Davis Co, Spain) were used for in-
duction and full anaesthesic purposes, re-
spectively. Diazepam (MediBial, Portugal) 
was used for myorelaxation during surgical 
procedures. Strips of ITLC-SG (Instant 
thin-layer chromatography – silica gel) was 
obtained from Gelman Sciences Inc., Ann 
Arbor, USA and Whatman no. 1 paper 
(Whatman, UK) were used for chromato-
graphic evaluation of labelling efficiency 
and radiochemical purity. All chemicals and 
reagents not specified in the text were of 
analytical grade or equivalent.
Preparation of liposomes
Liposomes were prepared according to the 
seven formulations listed above, without 
further purification of the lipids.
Typically, mixtures of the appropriated li-
pids, in concentration of 50mg/ml, were 
dissolved in 2 ml of chloroform in a round-
bottom flask, and the lipid solutions were 
rotary evaporated to dryness at room tem-
perature, under reduced pressure and inert 
atmosphere, for about 2 hours, to form a 
thin lipid film, which had been dried in 
vacuum overnight17,21. Following complete 
chloroform evaporation, the lipid mixture 
films were hydrated with 100 mM reduced 
glutathione (GSH) in 0.9% saline by vigo-
rous vortex mixing22-25. Next, the round-
bottom flask was placed in a 65ºC water 
bath for 10 min. This procedure (heating 
followed by vigorous mixing) was repeated 
twice, allowing the formation of multila-
mellar liposomes.
The multilamellar liposomes were then ex-
truded at 70ºC through two stacked poly-
carbonate filters (Nucleopore, CA, USA) of 
100 nm pore size, mounted in a mini-ex-
truder (LiposoFast™, Avestin, Canada) fit-
ted with two 0.5 ml Hamilton syringe 
(Hamilton, NV, USA)26-28. The samples 
were subjected to 20 passages through the 
filters, to form unilamellar liposomes, with 
a small polydispersity index.
After processing, the vesicle suspension was 
eluted through a Sephadex G-25 gel mo-
lecular exclusion chromatography minico-
lumns at room temperature, to remove any 
extravesicular GSH29-32.
The minicolumns were mounted in 1 ml 
tuberculin syringe tubes, plugging the bar-
rel with a small durapore® membrane filter 
(Millipore, Ireland) with a 0.45 μm pore 
size, and filling the syringes with Sephadex 
G-25 gel until the 1 ml mark. For the sepa-
ration, the columns were pre-washed with 
0.9% saline, pH=7.4, with a flow rate of ap-
proximately 21 ml/h and samples of 500 μl 
of vesicle solution from each formulation 
were applied to the minicolumns17,28,33.
Labelling of liposomes
For the labelling procedure, a modified 
methodology based on that described by 
Phillips et al. was used22,25,34,35.
HMPAO kits, containing 0.5 mg exameta-
zime, 7.6 μg SnCl2 and 4.5 mg NaCl were 
reconstituted with 740 MBq (20 mCi) of 
99mTc pertechnetate freshly eluted in 1 ml of 
0.9% NaCl solution and incubated for 5 
min at room temperature.
The reconstituted kits were checked for the 
presence of primary lipophilic 99mTc-HM-
PAO complex and for contamination by 
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free pertechnetate, reduced hydrolysed 
99mTc and secondary hydrophilic 99mTc-
HMPAO complex using a three step thin-
layer ascendant chromatography system, as 
recommended by the manufacturer. Ac-
cording to the manufacturer’s recommenda-
tions for cerebral blood flow studies, only 
kits where the primary lipophilic HMPAO 
complex was greater than 80% were used 
for liposome labelling. 99mTc-HMPAO was 
then added to 1.5 ml of each GSH contain-
ing liposome formulation and incubated at 
room temperature, for 30 min.
After the incubation period, liposomes were 
separated from any contaminant by passage 
through a second Sephadex G-25 gel mini-
column, prepared as referred above.
The labelling efficiency of 99mTc-HMPAO-
liposomes was checked by instant thin layer 
chromatography – silica gel (ITLC-SG) de-
veloped in 0.9% saline. With this system, 
the liposomes remain at origin, while the 
contaminants move with the solvent 
front36-38.
In order to verify that the 99mTc-HMPAO 
was in the liposome aqueous phase, during 
the second Sephadex G-25 gel molecular 
exclusion chromatography, 120 eluted frac-
tions of 250 μl were collected and analysed 
for radioactivity.
Liposomes size and surface charge 
measurements
The vesicle size distribution was determined 
by quasi elastic light scattering analysis, 
using a Coulter N4 Plus. Quasi elastic light 
scattering, also referred to dynamic light 
scattering or photon correlation spectros-
copy, employs digital self-correlation to 
analyse the fluctuations in scattered light in-
tensity generated by the diffusion of vesicles 
in solution39-41. The measured diffusion co-
efficient was used to obtain the average hy-
drodynamic radius and, hence, the mean 
diameter of the vesicles14,42.
The surface charge of the liposomes was de-
termined by laser Doppler velocimetry using 
a Coulter Delsa 440, which performed mea-
surements at 4 light incidence degrees: 
34.7º, 26º, 17.4º and 8.7º. These data al-
lowed the calculation of the electrophoretic 
mobility and zeta potential of the samples.
Stability studies
The temporal wall integrity of the different 
liposomal formulations was evaluated in 
vitro by ascendant microchromatography. 
In this system, a decrease on labelling effi-
ciency represents a loss of aqueous liposo-
mal content, which is an indicator of wall 
integrity.
Strips of ITLC-SG with saline as mobile 
phase were used, to evaluate the disruptive 
effects of biological fluids on the wall of the 
different liposomal formulations.
Liposome stability was determined by incu-
bating at 37ºC a sample of each different 
radiolabelled liposomal formulation in sa-
line, human serum, human plasma and hu-
man serum albumin solution (4mg/ml). 
Solutions were tested fresh and after incuba-
tion at 56ºC for 30 min with the purpose of 
deactivating the complement of blood frac-
tions. The saline and human serum albumin 
solutions were used for cross control14,43.
As an additional confirmation of stability, 
the aqueous liposomal content loss was 
checked, every 30 minutes, until 5.5 hours 
after the second Sephadex G-25 gel molecu-
lar exclusion chromatography. Analysis was 
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done using the ITLC-SG/saline system des-
cribed above.
As the liposomes will be administered as aero-
sols, the effect of the 2.7 MHz ultrasound on 
the integrity of the liposomal wall was also 
checked. Samples of the different formula-
tions were analysed by microchromatography, 
using the system previously described, before 
and after 3 min nebulisation44,45,46.
Aerosol production
An ultrasonic nebuliser (Heyer Ultraschall 
Verebler 69, Germany) generating ultra-
sound (US) of 2.7 MHz frequency was used 
for aerosol production. The water used in 
the reservoir was cooled down to 5-6ºC in 
order to minimise the effects of temperature 
increase during aerosolisation.
Toxicity
Liposomal cytotoxicity was studied in a hu-
man lymphomonocytic population. Cells 
were incubated with and without the lipo-
somal formulations at different concentra-
tions during 4 hours at 20ºC. After, the cells 
were labelled with membrane markers 
(CD3, CD14 and HLA-DR) and incubated 
during 10 min at 20ºC. Cells were then 
washed with PBS and analysed by flow cy-
tometry.
In terms of radiotoxicity, the absorbed doses 
were calculated by the absorbed fraction 
method, applying the MIRD (Medical Inter-
nal Radiation Dose Committee) rules47,48.
Molecular modulation studies
In order to establish the comparison be-
tween the Bacillus subtilis spore and lipo-
somes walls, a specific program of molecular 
modulation (CACHE, Molecular Oxford) 
was applied. With this program the stearic 
structures corresponding to the minimum 
of potential energy were calculated, as for 
the wall of Bacillus subtilis spores and for the 
wall of liposomes.
For the calculation of the Van der Walls ra-
dius, we used an algorithm of molecular 
mechanics minimisation, named MM2.
In vivo studies
Material
In the scanning electron microscopy (SEM) 
studies we used a scanning electron micros-
cope Jeol T330 for the evaluation in an 
adult male Wistar rat.
To accomplish the in vivo dynamic studies, 
we used 20 pigs (Sus scrofa). For the image 
acquisition, a gamma camera General Elec-
tric 400 AC (G.E. Healthcare, Milwaukee, 
USA), controlled by a Genie ACQ compu-
ter, running on compatible platform IBM 
was used.
The data were processed in a dedicated 
workstation Hewlett Packard (Genie P & 
R), which runs in an UNIX platform. The 
samples were weighted in a precision scale 
(Precisa 205A Superbal-series) and counted 
in a well count (DPC-gamma C-12, Los 
Angeles, USA)
SEM studies
For the visualization of the deep lymphatic 
drainage, the modulated liposomes must 
reach both the juxta-alveolar lymphatic ves-
sels and the lymphatic capillaries associated 
to the respiratory bronchioles, i.e. the lipo-
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somes must reach the respiratory area of the 
lung. We choose the inhalatory administra-
tion as an aerosol, produced by an ultrason-
ic nebuliser, with a frequency of 2.7 MHz, 
once targeting the lung exchange area is 
much more dependent on the size of aerosol 
droplets than the liposomes diameter, since 
they are smaller44,45.
For the confirmation of the liposomes de-
position on the alveolar epithelium admi-
nistered by inhalation, SEM studies were 
carried out on an adult male Wistar rat after 
aerosol inhalation of F formularization lipo-
somes.
Twenty minutes after inhalation, and under 
deep anaesthesia, the rat thorax was opened 
and the vascular compartment perfused 
with saline at 37ºC, with a flow rate of 7 
ml/min, by injection in the right ventricle. 
After, an aortotomy at abdominal level was 
performed, in order to purge the perfusion 
liquid. The vascular flush out take about 
two minutes, until the perfusion liquid be-
came clear. After, a fixation solution of 
formaldehyde 4%, v/v, in phosphate buffer 
0.1 M, pH = 7.4 at room temperature, was 
perfused during 3 – 5 minutes, maintaining 
the animal condition and perfusion access.
After fixation, lung samples with dimen-
sions of about 3x3x3 mm were taken, which 
were immerse in a solution of formaldehyde 
4%, v/v, in phosphate buffer 0.1 M, pH = 
7.4. The samples dehydration was per-
formed with acetone, as substitution mean, 
in successive passages with increasing con-
centrations since the 20% v/v to 100% v/v. 
Afterwards, the samples had been dried by 
CO2 critical point, in an unit 3000 CP (Po-
laron), equipped with a high-pressure and 
temperature manometer, being the tempe-
rature variation inside of the chamber as-
sured by circulated boiled water (Thermed 
5001 – GLF). Finally, the samples were 
placed in copper supports by glue with sil-
ver (Electron Microscopy Sciences), to be 
gold coated by cathode evaporation (Pola-
ron). The samples observation was carried 
out in the scanning electron microscope 
Jeol T330, selected to the capture of secon-
dary electrons and submitted to a 15 kV of 
potential difference.
Lymphoscintigraphic studies
For the in vivo lymphoscintigraphic studies, 
liposomes labelled with 99mTc-HMPAO 
were administered through inhalation to a 
20 Sus scrofa.
For these studies, the Sus scrofa had been 
submitted to an anaesthetic protocol con-
sisting of an anaesthetic induction with 40 
mg of azoperone by intramuscular injec-
tion, immediately followed by intravenous 
infusion of ketamine hydrochloride (35 mg/
kg). For muscle relaxation we used diazepam 
(10 mg by intramuscular injection). During 
all procedures, the animals had an intratra-
cheal tube of 4 mm of diameter inserted in 
the trachea and were kept in spontaneous 
breath with a mixture of air enriched with 
therapeutic oxygen. During all the study, 
the animals kept a nasogastric tube, in order 
to guarantee the non deglutition of secre-
tions, and consequently the non contami-
nation by digestive route. The bladder of all 
animals was catheterised in order to main-
tain the bladder free of urine during all the 
study.
After aerosols administration, a dynamic ac-
quisition, at thoracic level in posterior view 
was carried, through the gamma camera 
coupled with a high resolution parallel hole 
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collimator, of 120 images of 64×64 pixels, 
with an individual duration of 30 seconds.
After this sequence, static images of 128×128 
pixels at thoracic and abdominal levels were 
acquired at 60, 90, 120, 150, 180, 210 and 
240 minutes after the inhalation.
The images acquired with liposomes la-
belled with 99mTc-HMPAO, were processed 
with homemade software specially deve-
loped for this study. With this processing, 
each image is submitted to a subtraction of 
the lung activity corresponding to the re-
spective time, considering the effective half-
life of liposomes. This subtraction allows 
evidencing the lymphatic nodes.
For comparison of the images acquired after 
inhalation of labelled liposomes, one pig 
inhaled an aerosol of native HMPAO labelled 
with technetium-99m. After this inhalation, 
a dynamic acquisition was performed, at 
thoracic level, during 20 minutes, for ma-
trix of 64×64 pixels, 6 images per minute, 
followed of static images of the thorax and 
abdomen, of 128×128 pixels at 20, 30, 45 
and 60 minutes after the inhalation too.
To confirm the localization of the lymphatic 
abdominal nodes, two pigs were injected in 
the first interdigital space of both posterior 
members, with nanocolloids of human al-
bumin (Nanocoll, Amersham-Sorin, Italy) 
labelled with 99mTc, which is a specific tracer 
for the lymphatic drainage and lymphatic 
nodes. Immediately after the injection, a 
dynamic acquisition at abdominal level, in 
anterior view, of 120 images of 64×64 pixels 
with individual duration of 30 seconds, 
was performed. After this sequence, static 
images of 128×128 pixels at 60 and 90 mi-
nutes after interdigital injection were ac-
quired.
Also to confirm the lymphatic abdominal 
nodes, two animals had been submitted to 
an interdigital injection, in the left posterior 
member, of methylene blue dye that is 
drained by lymphatic system. These animals 
had been submitted to a laparotomy with 
abdominal dissection, for direct visualiza-
tion of the lymphatic vessels (Fig. 5).
For cross control of in vivo liposomes stabi-
lity, in eight pigs during the image acquisi-
tion, urine samples and blood samples at 5 
min, 30 min, 1, 2, 3, 4, 5 and 6 hours had 
been collected.
These samples were weighed, counted in a 
well counter and the specific counts were 
calculated and converted into % of the ad-
ministered activity, considering 100% the 
maximum of the pulmonary activity. The 
goal was to infer the leak of the water con-
tent of the liposomes, once this content is 
Fig. 5 – Interdigital injection of methylene blue in interdigital space of the left posterior member (left) and explorative laparo-
tomy with visualization of lymphatic drainage (right)
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hydrosoluble and would pass to the blood 
and then, excreted by renal system.
We also wanted to verify, through the ima-
ges, if there was any localizations correspon-
ding to the presence of liposome in the sys-
temic circulation through venous return, as 
well as the activity concerning the loss of the 
liposomes water content, as a consequence 
of wall liposomal degradation. For this pur-
pose, in the acquired images, we drew re-
gions of interest (ROIs) in some areas (lung, 
liver, interpulmonary area, abdominal aorta, 
renal area and bladder projection area) on 
the times corresponding to the blood collec-
tion. For each ROI, the % of activity was 
calculated, considering the 100% the maxi-
mum of the pulmonary activity.
Statistical methods
Data were reported as mean ± standard de-
viation. For comparison of the group re-
sults, t-Student analysis was applied to the 
means. The accepted probability for a sig-
nificant statistical difference was p<0.05.
Results
Liposomes
Our rationale was to develop liposomes 
with similar physical properties to the genus 
Bacillus, once is recognized its preferential 
lymphatic drainage when present in human 
respiratory system.
We started with seven formulations, with 
the purpose to obtain at least one formula-
tion characterized by good stability, easiness 
to label and with good specificity for the 
lung lymphatic. We used the membrane of 
the Bacillus subtilis spore as a model, once 
our previous experience in dogs showed its 
potential as a tracer of lung lymphatics.
The labelling efficiencies for the seven dif-
ferent developed formulations are presented 
in Fig. 6.
Ascendant chromatography in ITLC-SG/
saline clearly demonstrates the different 
99mTc-HMPAO labelling efficiencies for the 
various liposomal formulations. Formula-
tion A = 74.1±13.9%; formulation B = 
77.3±9.2%; formulation C = 47.5±7.4%; 
formulation D = 46.6±3.6%; formulation E 
= 28.1±4.3%; formulation F = 80.3±15.3%; 
formulation G = 63.1±21.8%.
These differences are related with the lipid 
composition of the liposomal bilayer. The 
liposomal formulations with cardiolipin 
showed the worst results. Oppositely, the 
presence of an amino sugar associated with 
cholesterol, even in small percentage, in-
creases significantly the radiolabelling effi-
ciency.
In vitro stability studies were done in saline, 
human serum, human plasma and human 
Fig. 6 – Labelling effi ciency (mean ± SD) of the seven liposomal formulations. The la-
belling effi ciency of the 99mTc-liposomes was evaluated by instant thin layer microchroma-
tography – silica-gel (ITLC-SG) with saline as solvent. In this system, the liposomes remain 
in the origin, while the contaminants go with the solvent front.
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serum albumin solution (4mg/ml) incuba-
ted at 37ºC, before and after 30 min heat-
ing at 56ºC to inactivate the complement of 
blood fractions. The results showed that 
formulations C, D and E besides its small 
labelling efficiency, presented a lower degree 
of stability in the presence of biological flui-
ds (Table I).
The results obtained for the labelling effi-
ciency with 99mTc-HMPAO and the in vitro 
stability in the presence of human serum, 
human plasma and albumin solution 
showed that formulations C, D and E pre-
sented not only some difficulties in labelling 
with this method but also showed some ins-
tability in the presence of the biological 
fluids.
As a result, these formulations were exclu-
ded from further testing, once the stability 
in presence of biological fluids was required 
if the liposomes will be used, in the future, 
as lung lymphatic tracers. Formulation G, 
was also excluded because its content in car-
diolipin, considered an immunogenic lipid.
At this stage, only the three remaining for-
mulations (A, B and F) presented potenti-
alities of usage for our objective.
On the other hand, as the final goal was to 
administrate the liposomes as aerosols, pro-
duced by ultrasonic nebulisation, the three 
formulations A, B and F were submitted to 
ultrasounds 2.7 MHz frequency for three 
minutes, to evaluate their action during 
aerosol production. The effect of ultrasound 
action in the stability of the labelled vesicles 
is shown in Table II.
These results indicate that for ultrasonic 
nebulisation at 2.7 MHz, there are no statis-
tically significant differences in the stability 
of the three liposomal formulations, al-
though formulation B appears to be the 
most affected and Formulation F presents 
the best results.
Fig. 9 shows the time course of aqueous li-
posomal content loss during 5.5 hours after 
the second gel chromatography.
Table I – Labelling effi ciencies (%) for the different liposomal formulations in presence of different fl uids (saline, human se-
rum, human plasma, human albumin solution), before and after heating at 56ºC during 30 min, for blood fractions comple-
ment inactivation
Form A 
(n=7)
Form B 
(n=7)
Form C 
(n=3)
Form D 
(n=3)
Form E 
(n=3)
Form F 
(n=7)
Form G 
(n=3)
Saline 56.9±5.9 69.9±6.8 47.5±7.4 46.6±3.6 28.1±4.3 60.7±10.3 63.1±21.8
Saline 56ºC 49.8±2.9 70.0±2.9 48.7±8.0 34.9±12.6 22.3±3.5 64.6±9.3 47.1±3.4
Human serum 61.1±3.2 76.6±5.5 37.4±10.0 37.7±13.3 21.6±5.7 65.9±4.1 51.3±14.8
Human serum 56ºC 57.0±5.7 77.4±9.5 25.2±5.6 40.4±14.7 22.1±4.9 68.4±9.2 55.6±12.7
Human plasma 58.9±4.5 76.0±3.2 23.8±8.1 40.1±12.4 18.5±5.0 62.3±3.0 51.6±10.2
Human plasma 56ºC 52.9±5.7 72.5±5.8 26.4±4.0 46.4±12.4 19.2±3.1 65.5±6.2 44.3±11.4
Albumin 50.9±6.5 66.3±6.5 31.0±13.3 42.3±21.3 – 59.0±4.9 66.8±4.5
Albumin 56ºC 51.4±8.8 67.6±8.5 18.9±3.2 51.5±11.4 17.6±4.6 63.3±7.7 47.1±16.4
Table II – Labelling fraction of the liposomal formulations A, 
B and F, before and after 2.7 MHz ultrasounds(US) action 
during three minutes
Form. A
(n=9)
Form. B
(n=4)
Form. F
(n=7)
Before US 80.1 ± 10.1% 82.8 ± 6.6% 88.7 ± 6.5%
After US 79.9 ± 10.3% 68.3 ± 24.6% 85.7 ± 5.4%
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The evaluation of the three formulations, 
using an ITLC-SG/saline microchromato-
graphic system for quantification of loss of 
radioactive fragments, which migrate with 
the solvent front, shows that although all 
formulations lose some of their content over 
time, formulation F appears to be the most 
stable.
Based on these results, formulation F was 
selected as the most promising candidate 
and was subjected to further tests to assess 
its suitability as an in vivo imaging agent.
The lipid bilayer of this formularization, 
based on the composition of the different 
coats of the Bacillus subtilis spores, is consti-
tuted by DSPC, PG, NAMA and CL with 
the following molar ratio 7.5:1.5: 0.5: 0.5.
To test non-encapsulated 99mTc-HMPAO, 
radiolabelled liposomes from the F formu-
lation, were submitted then to a second 
Sephadex G-25 gel molecular exclusion 
chromatography and 120 eluted fractions of 
250 μl were collected and analysed for ra-
dioactivity. As it can be observed in Fig. 10, 
the first 10 fractions, that included the lipo-
somal fractions, accounted for around 85 % 
of the total activity. The remaining activity 
(about 15%), considered as being the non-
encapsulated tracer, was eluted with the re-
maining fractions (Fig. 8).
To determine the vesicle size distribution, 
lipid concentrations of 50 mg/ml were 
passed 20 times through two stacked poly-
carbonate membranes of 100 nm pore size. 
Photon correlation spectroscopy studies in-
dicated a mean diameter of 124.0 ± 32.1 nm 
and a polydispersity index of 0.09 (n = 3) 
(Fig. 9).
Electrophoretic mobility and zeta potential 
determinations of similar samples, obtained 
by laser Doppler, led to values of 4.1 ± 0.2 
Fig. 7 – Temporal evaluation of the losses of liposomal aqueous content for the formulation 
A (n=12), B (n=7) and F (n=10) by ascending microchromatography (ITLC-SG/saline)
Fig. 8 – Chromatography in column of Sephadex G-25 of liposomes of F formularization 
(n=4). Samples of 500 μl of the liposomal suspensions had been placed in each column 
and eluent fractions of 250 μl were collected. This graph represents the activity of each 
fraction vs. number of fractions
Fig. 9 – Unimodal analysis of the liposomes diameter distri-
bution
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μm cm V-1 s-1 and 52.8 ± 3 mV respectively 
(n = 3) (Fig. 10).
In order to evaluate possible ageing effects 
on this formulation, the samples were left 
for 6 months at 4ºC before being retested. 
The results for the different parameters, i.e., 
mean diameter (150.6 ± 48.2 nm), polydis-
persity index (0.17), electrophoretic mobi-
lity (4.2 ± 0.6 μm cm V-1 s-1) and zeta po-
tential (53.5 ± 6.6 mV) do not show 
statistically significant differences when 
compared with the values obtained with 
fresh liposomes.
The evaluation of cytotoxic effects in a hu-
man lymphomonocytic population, by flow 
cytometry, demonstrated that formulation F 
in high concentrations appears to modify 
the ratio of mononuclear cells, inducing a 
decrease in the total number of lymphocytes. 
However, in spite of the decrease in the auto-
fluorescence the lymphocytes are not acti-
vated as it is showed by the CD3 expression. 
The monocytes seemed to have some activa-
tion, as shown by the analysis of CD14 ex-
pression. On the other hand, in small con-
centrations, the F formulation liposomes did 
not induce any alteration in the distribution 
or activation of the two mononuclear lines. 
In conclusion, the cytotoxicity test was con-
sidered negative and the aggressiveness of 
the formulation F liposomes estimated as 
being very low (Fig. 11).
In terms of radiotoxicity, for an activity of 
111 MBq deposited over the alveolar-capil-
lary membrane, during the inhalation of the 
99mTc-Liposomes, the absorbed dose was 
calculated by the fractional method using 
standard MIRD rules38-39. The absorbed 
dose was shown to be in the same order of 
Fig. 10 – Distribution of the zeta potential for the different 
angles of incidence of the laser
Fig. 11 – Distribution of the cellular markers for the some cultures carried out with the some 
membrane markers
Fig. 12 – Stearic structures of the liposomes wall of formu-
larization F (on the left) and Bacillus subtilis spore wall (on 
the right), corresponding to the minimum potential energy, 
obtained by a specifi c software of molecular modulation
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magnitude as the obtained with routine 
Nuclear Medicine studies for the evaluation 
of alveolar-capillary permeability.
After in vitro evaluation of liposomes of for-
mulation F, which showed to be suitable for 
our purpose, we wanted to analyze based on 
the knowledge of its complete composition, 
the ternary and quaternary structure of the 
liposomes wall in order to compare them 
with the Bacillus subtilis spore wall. To 
achieve this goal the stearic structures cor-
responding to the minimum potential ener-
gy were calculated for both, Fig 12.
Applying an algorithm for molecular me-
chanics minimization, the calculation of the 
Van der Walls radium showed that the mo-
lecular compaction of these two structures 
seemed to be similar, Fig. 13. Additionally, 
the hydrophilic surface terminations were 
also alike.
In vivo studies
Scanning electron microscopy
In order to confirm that the liposomes were 
deposited on the alveolar epithelium, we 
submitted a Wistar rat to an aerosol inhala-
tion of a solution containing liposomes of 
formularization F. As we can observe on 
Fig. 16, twenty minutes after the liposomes 
inhalation, they are deposited on the lung 
alveolar surface. We can also verify that they 
are homogeneously distributed all over the 
alveolar surface.
Once they reach the alveolar epithelium, 
the liposomes seem to be phagocyted by the 
alveolar macrophages and after, drained by 
the lymphatic channels (Fig. 15).
In spite of this evidence, we cannot exclude 
the possibility of the direct passage of lipo-
somes through the intercellular spaces, as 
appears to be the situation showed in the 
Fig. 14.
Fig. 13 – Van der Walls radium of liposomes wall of formularization F (on the left) and the Bacillus subtilis spore wall (on the 
right), obtained through an algorithm of energy minimization. We can observe the similar molecular compaction.
Fig. 14 – SEM image, obtained twenty minutes after the li-
posomes of formularization F aerosol inhalation. We can 
see its homogeneous distribution on the alveolar surface
Nanorradiolipossomas modulados molecularmente para estudar 
a drenagem linfática pulmonar profunda
Maria Filomena Rabaça Roque Botelho, Maria Alcide Tavares Marques, Célia Maria Freitas Gomes, Augusto Marques Ferreira da Silva, 
Vasco António Andrade Figueiredo Bairos, Manuel Amaro de Matos Santos Rosa, Antero Pena Abrunhosa, João José Pedroso de Lima
R e v i s t a  P o r t u g u e s a  d e  P n e u m o l o g i a278
Vol XV  N.º 2  Março/Abril  2009
Lymphoscintigraphy studies
When we analyse the images obtained dur-
ing the dynamic acquisition in the 20 pigs, 
without any image processing, we can al-
ready observe interpulmonary communica-
tions in the images obtained in first 5 min-
utes, and infradiaphragmatic nodes between 
the 10 and the 20 minutes. We can also vi-
sualise some other abdominal localisations 
after the first 20 minutes. After image pro-
cessing, these evidences were more signifi-
cant.
In the Fig. 16 corresponding to the pig 
number 23 we can see, in the image ob-
tained at thoracic level, 5 minutes after the 
inhalation of modulated liposomes, the hi-
lar and interpulmonary lymphatic channels 
as well as the initial transdiaphragmatic 
drainage (Fig. 16-a). Nine minutes after the 
inhalation, the interpulmonary drainage is 
more individualised and the transdiaphrag-
matic one is already patent (Fig. 16-b). At 
20 min the periaortic ganglia starts to be ap-
parent (Fig. 16-c). At 30 minutes ganglia of 
renal hilum were visualized (Fig. 16-d) and 
after 60 minutes the bladder area was al-
ready evident.
The study carried out with HMPAO la-
belled with 99mTc aerosols, in another ani-
mal, in order to compare the images ac-
quired after inhalation of labelled liposomes 
does not show any type of lymphatic gan-
glia, in spite of the dispersed abdominal ac-
tivity, with individualization of the liver and 
the kidneys (Fig. 17).
The images obtained during the indirect 
lymphoscintigraphy carried out with nano-
colloids of human albumin labelled 99mTc, 
in order to confirm the localization of the 
abdominal lymphatic ganglia show that, 17 
minutes after the interdigital injection and 
Fig. 15 – SEM image showing a liposome being phagocyted 
by an alveolar macrophage
Fig. 16 – Thoracic images in posterior view after 99mTc-Liposome aerosol inhalation, in 
the pig ner 23. a) 5 min after the inhalation – Visualization of hilar drainage; b) 9 min after 
– transdiaphragmatic drainage; c) 20 min – initial visualization of aortic chain; d) 30 min – 
renal hilar ganglia
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passive movements, the lymphatic trunks of 
the inferior members were visualised. In the 
studies performed, the popliteal ganglia 
were systematically visualized before 30 
minutes, usually at 25 minutes and the gan-
glia of the aortic chain after 30 minutes 
(Fig. 18).
In Fig. 19, we can see the images of the tho-
racic region in posterior view and the ab-
dominal region in anterior view both ob-
tained 1 hour and 1.5 hours after labelled 
liposomes inhalation, concerning the ani-
mal ner 23. As we can observe, the infradia-
phragmatic, right renal hilum, pelvic region 
and bladder area localizations are apparent.
In the delayed scintigraphic images, ob-
tained at 2 and 3 hours after inhalation, we 
visualize more intensively the same projec-
tion areas (Fig. 20).
To confirm the abdominal lymphatic gan-
glia by direct visualization, two animals 
were submitted to an indirect lymphogra-
phy obtained after interdigital injection in 
the left posterior member of methylene 
blue, a dye that is drained by lymphatic ves-
sels, followed by abdominal laparotomy. In 
Fig. 21, we can see the early images of the 
direct abdominal and pelvic region visual-
ization of the animal ner 23, after interdigi-
tal injection of the referred dye. We can no-
tice 2 areas coloured in blue, one behind the 
bladder and another one in the abdominal 
wall just over the bladder.
Fig. 17 – Images in posterior view, obtained after aerosol inhalation of 99mTc-HMPAO. The 
images didn’t show any nodular localization, in spite of dispersed abdominal activity
Fig. 18 – Images in anterior view of the pig ner 15, obtained after interdigital injection in both the posterior members of nano-
colloids of human albumin labelled with 99mTc
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Fig. 19 – Images obtained 1 hour and 1.5 hours after 99mTc-liposome aerosol 
inhalation, in the animal ner 23. The infradiaphragmatic, right renal hilum, pelvic 
region and bladder area localizations are apparent
Fig. 20 – Images obtained at 2 and 3 hours after the 99mTc-liposome aerosol inha-
lation, in the animal ner 23. The infradiaphragmatic, right renal hilum, pelvic region 
and bladder area localizations are much clearer
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In the later times, the same two areas re-
ferred above were also directly visualised, 
but more intensively coloured by methylene 
blue (Fig. 22).
The comparison of the abdominal images 
obtained 60 minutes after liposomes la-
belled with 99mTc inhalation and 60 mi nutes 
after the indirect lymphoscintigraphy by in-
terdigital injection of human albumin nano-
colloids also labelled with 99mTc, allows to 
confirm that the visualized areas seemed to 
be in the same projections (Fig. 23).
Also in the animal ner 23 crossed control 
studies of the in vivo liposomes stability 
were done. For this, during image acquisi-
tion blood samples were collected at 5 min-
utes, 30 min, 1, 2 and 3 hours after 99mTc-
Liposomes inhalation. Urine was also 
obtained 3 hours after labelled liposomes 
inhalation. These samples were weighed, 
counted in a well counter and the specific 
counts calculated, which were converted 
into % of the injected activity (241 MBq), 
considering the 100% as the maximum 
lung activity.
As we can see in the graph of Fig. 24, the 
blood and urinary activity were particularly 
reduced, which indicates a good in vivo li-
posomes stability of formulation F.
In the animal ner 23, we controlled through 
the images, the existence of lymphatic nodes 
areas corresponding to the presence of lipo-
some in the systemic circulation, through 
venous return, as well as the activity corres-
ponding to liposomal content leak, as result 
of biodegradation.
On the graph of Fig. 25 we can see the time 
distribution of the percentage of the admi-
Fig. 21 – Early images of the indirect lymphography obtained after interdigital injection of methylene blue in the left inferior 
member
Fig. 22 – Delayed images of the indirect lymphography obtained after interdigital injection of methylene blue in the left infe-
rior member
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nistered activity in each ROI drawn in the 
images of the corresponding times to the 
blood and urine collections. As the normal-
ization was made relatively to the pulmo-
nary activity, considering the 100% as the 
maximum lung activity, we removed the 
lung column on the graph, allowing this 
way a better appreciation.
In Fig. 26, we can see another example, cor-
responding to the animal ner 18. After 99mTc-
Liposome aerosols inhalation of formulation 
F the acquired images, without image pro-
cessing, showed already visible lymphatic 
node areas. However, after image processing, 
this evidence was substantially improved.
In the image obtained 5 minutes (Fig. 26-a) 
after the inhalation, the hilar drainage chains 
are visualized, which became more indivi-
dualised at 10 minutes (Fig. 26-b). At 13 
minutes (Fig. 26-c) there was already trans-
diaphragmatic drainage, being clearly visible 
node areas in more delayed images (Fig. 26-
d). At 25-27 minutes, aortic chain ganglia 
began to be visualised.
Fig. 25 – Graph that shows the time distribution of the % of 
administered activity, in each ROI in the animal nº 23. The 
column corresponding to the lung activity was excluded
Fig. 23 – Abdominal scintigraphic images, obtained 60 minutes after liposome labelled with 99mTc inhalation (on the left) 
and 60 minutes after the interdigital injection of nanocolloids of human albumin labelled with 99mTc (on the right)
Fig. 24 – Graph that shows the % activity of the blood and 
urine samples, collected during images acquisition in the 
animal ner 23
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Fig. 26 – Thoracic images in posterior view obtained after 99mTc-Liposome aerosol inhala-
tion, in the pig nº 18. a) 5 min after the inhalation – visualization of hilar draining chains; b) 
10 min after the inhalation – individualisation of hilar draining chains; c) 13 min after the 
inhalation – transdiaphragmatic drainage; d) 30 min after the inhalation – initial visualiza-
tion of the aortic chain ganglia
Fig. 27 – Images obtained 1 hour and 1.5 hours after the 99mTc-liposome aerosol inhalation, 
in the animal ner 18. The infradiaphragmatic localizations, aortic chain, and in the renal 
projection areas, all over the ureter and in the bladder projection area are clear
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In Fig. 27, we can observe the delayed images, 
both thoracic and abdominal, in anterior view, 
at 60 minutes and 90 minutes after liposomes 
inhalation. We can see the activity on the aor-
tic chain, and on renal projection areas, in-
cluding ureters and bladder projection.
These last localizations, that can put same 
interpretative doubts, are clarified by the di-
rect visualization through indirect lymphog-
raphy obtained after methylene blue inter-
digital injection (Fig. 28). In this image we 
can observe the lymphatic drainage vessels 
from the perivesical ganglia surrounding the 
ureter till the renal hilum.
Additionally, the blood and urine samples 
collected during the study, following the 
methodology described above, which results 
were presented as % of the maximum lung 
activity (100%) showed a very low blood 
pool activity, while in urine it was virtually 
insignificant (Fig. 29).
The percentual activity at the ROIs shows a 
similar distribution to the animal previously 
shown (Fig. 30).
The results obtained by analysis of blood 
and urine samples collected during the ima-
ge acquisition, for a group of 8 pigs, can be 
observed in the graph of Fig. 31. These sam-
ples were weighed, counted in a well coun-
ter, normalized for the activity of a known 
sample and the average percentual activity 
was calculated considering as 100% the 
maximum lung activity.
As observed, there are some blood and uri-
nary activity, but in very small amounts and 
clearly dependent on the water content leak 
by the liposomes, already analysed.
Discussion and conclusions
Liposomes production
The goal of this work was to produce and 
characterise liposomes that, after being 
Fig. 28 – Images of the early times of the indirect lymphography obtained after interdigital injection of methylene blue in the 
left inferior member
Fig. 29 – Graph that shows the percentual activity in the blood and urine samples, col-
lected during the image acquisition in the animal ner 18
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inhaled, would be preferentially cleared by 
the lung deep lymphatics.
The lymphatic system is of vital importance 
in the alveolar and interstitial clearance of a 
great diversity of substances (particles, dusts 
and pathogenic agents) that reach the alveo-
li, which must be removed in order to en-
sure gas exchange through the alveolar-ca-
pillary membrane.
The preferential lymphatic drainage of some 
microorganisms correlates with some spe-
cific surface components.
Several studies show a systematic and faster 
lymphatic removal of anionic than the ca-
tionic compounds with same molecular 
weight, which means that the pulmonary 
endothelium acts as a positive barrier13. This 
was the reason why the seven studied for-
mulations present negative surface charge.
The liposomes preparation procedures must 
to obey to very restricted requirements. As 
our purpose was to obtain liposomes of si-
milar dimensions of bacillus, but with a 
relatively high water core in order to retain 
the tracer, the unilamellar liposomes seemed 
to be the most appropriated. Additionally, 
as the used tracer to label the water phase Fig. 31 – Graph showing the average percentual activity of the blood and urine samples, collected during the image acquisition for the group of 8 studied animals
was the 99mTc which has a physical radioac-
tive period of 6 hours, the radionuclide en-
capsulation during the lipid film hydration 
was not convenient due to the long proce-
dure time.
Keeping in mind these assumptions, the de-
veloped liposomes should be small, unila-
mellar, and would present some degree of 
negative surface charge in order to favour 
their lymphatic uptake49. On the other hand, 
the vesicles should be amenable to labelling, 
non-immunogenic and present enough sta-
bility to allow aerosolisation and the imple-
mentation of in vivo imaging studies46.
As consequence, we choose the extrusion 
technique through polycarbonate membranes 
Fig. 30 – Time distribution of the percentual activity for liver, interpulmonary region, abdominal aorta and renal area (on the 
left) and for bladder projection (on the right) of the animal ner 18
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with pores of 100 nm diameter and the label-
ling of the liposomes after its production, im-
mediately before their administration.
According to several authors, repetitive ex-
trusion of multilamellar vesicles above phase 
transition temperatures, provides an easy and 
reproducible method for producing unila-
mellar homogeneous vesicles of defined size 
from long-chain saturated phosphatidylcho-
lines8,26,27,28,41, without the need of organic 
solvents, detergents or sonication and with 
good encapsulation efficiencies. This choice 
was also reinforced by the fact that the small 
size liposomes radiolabelling efficiency was 
less then 5%, when the labelling procedure 
occurs during the hydration of the lipid films, 
before the vesicles formation49.
Additionally, the fact of the extrusion under 
moderate pressures does not need organic 
solvent or detergents is another advantage, 
related to the small possibility of occurrence 
of inflammatory reactions of the broncho-
alveolar epithelium, since these liposomes 
must be inhaled. The extrusion under mo-
derate pressures can be applied to long chain 
saturated phospholipids as well, since the 
extrusion temperature will be higher then 
the phase transition temperature17.
As we intended to use a fast and efficient 
labelling technique, our choice was 99mTc-
HMPAO which is added to the reduced 
glutathione containing liposomes in the 
aqueous phase25,38,50.
Although, in general terms, our results are in 
agreement with those obtained by other au-
thors, some dependence of the labelling effi-
ciency with the bilayer lipidic composition 
was observed (from 28.1 ± 4.3% for formu-
lation E to 80.3 ± 15.3% for formulation F, 
as shown in Fig. 6), besides all formulations 
contained DSPC, a long chain saturated li-
pid. Related to the long chain saturated lip-
ids, several authors recommended their use 
when stable liposomes are required, like when 
they are used as drug delivers. These lipids 
are also associated to bigger in vivo liposomes 
stability17. However, the addition of mem-
brane stabilizers, like cholesterol and amino-
sugar derivatives22,51,52 are other factors capa-
ble to influence the liposomes behaviour, as 
is confirmed by our results (Tables I and II).
The formulations with cardiolipin showed 
the smallest labelling efficiency, probably 
due to an excess of negative surface charge. 
Additionally, the presence of cholesterol 
alone does not appear to improve labelling 
efficiency (Formulation E = 28.1 ± 4.3%), 
unless a residue is added (Formulation G = 
63.1 ± 21.8%). When the negative surface 
charge is decreased, using only PG as nega-
tive lipid (Formulations A, B and F), an in-
crease in labelling efficiency is observed. 
However, there aren’t significant differences 
in labelling efficiency among these formula-
tions, which means that the choice of the 
residue is not a determinant factor.
It is also known that the in vivo liposomes 
stability is influenced not only by the lipidic 
composition but also, that can be modified 
by complement action, phospholipids in-
terchanges and hydrophobic action of plas-
matic proteins and phospholipases14.
Our results of in vivo stability evaluation 
showed that the phospholipid composition 
and chemical properties of liposomal formu-
lations determine its vulnerability to the dis-
ruptive effect of the human blood serum and 
plasma14. In fact, we verified that both hu-
man serum and plasma led to a decrease in 
the labelling efficiency of formulations C, D 
and E, although only formulation C presen-
ted statistically significant differences (t=2.4; 
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p=0.05 for human serum; t=2.0; p=0.05 for 
human albumin solution). All other formu-
lations (A, B, F and G) showed an increase in 
labelling efficiency in the presence of human 
serum and plasma with statistically signifi-
cant differences for formulations A (t=3.2; 
p=0.01 for human serum and plasma) and G 
(t=2.8; p=0.01 for human albumin solution). 
These results allow us to conclude that for 
these four formulations, the biological fluids 
do not induce leaks of its aqueous content.
The results of the stability studies associated 
to those of the labelling efficiency, allowed 
to exclude formulations C, D and E, once 
the chosen formulation must be stable and 
to have a good labelling efficiency. More-
over, formulation G was also discarded due 
to the presence of a potentially immuno-
reactive component (cardiolipin).
In order to assess the stability of the remain-
ing formulations (A, B and F) to ultrasonic 
nebulisation, the labelling efficiency of these 
formulations was evaluated immediately after 
being submitted to 2.7 MHz ultrasound ac-
tion for 2 minutes. The results obtained (Ta-
ble II) didn’t show any statistically significant 
differences in labelling efficiencies before and 
after ultrasound action46,52,53. This stability to 
ultrasound action is crucial, once its adminis-
tration will be performed as an aerosol.
The three formulations were also assessed 
for loss of entrapped contents over 5.5 
hours. This evaluation showed that formu-
lation F presented the best performance, 
presenting the greater temporal stability, 
with almost no loss of aqueous contents 
(Fig. 7), which can be related with the si-
multaneous presence of cholesterol and N-
acetyl muramic acid.
In opposition, less favourable stability re-
sults have been shown by formulation B, 
which differs from formulation F only by 
the absence of cholesterol whilst formula-
tion A only had glutamic acid. According to 
this results, formulation F was selected as 
the most promising candidate.
The choice of correct lipid composition to 
produce liposomes as promising radiophar-
maceutical carriers for visualization of lung 
lymphatics, to be administered as aerosols, 
must obey to several criteria: to be specifi-
cally drained by lung lymphatic vessels, to 
be easily and efficiently labelled, to be stable 
in presence of biological fluids, not induce 
immune response and to be resistant to ul-
trasound action. The results of in vivo tests 
described in chapter 3 allowed to conclude 
that formulation F (DSPC:PG:NAMA:CL) 
was the one that congregate the best charac-
teristics for the considered goal. This for-
mulation was submitted to other in vitro 
tests for a better physicochemistry charac-
terization.
During the second passage of liposomes la-
belled with 99mTc-HMPAO by the Sepha-
dex G25 column, for removing non encap-
sulated 99mTc-HMPAO, 120 fraction of 
250μl were collected and counted in a well 
counter. The peak observed in Fig. 8 corre-
sponds to the liposomes fraction that was 
eluted in the first 10 collected fractions. The 
activity counted in the remaining fractions 
corresponded to the not encapsulated tracer. 
This procedure assures that the collected la-
belled liposomes do not contain radiocon-
taminants, which is of high importance for 
the image quality of the lymphatic lung 
drainage, without artefacts, after adminis-
tration as aerosol.
According to Nayar17, the extrusion under 
moderate pressures and above lipids phase 
transition temperature, allows to get unila-
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mellar liposomes of specific size, from satu-
rated long chain phosphatidylcholines, 
without the use of organic solvents, deter-
gents or sonication29.
A molecular model of a small section of the 
formulation F vesicles outer layer can be 
seen in Fig. 4 in comparison with a model 
of a similar section of the Bacillus subtilis 
spore wall. Structures were energy mini-
mized using a molecular mechanics (ex-
tended MM2) algorithm [CACHe, Oxford 
Molecular, Oxford, UK] until energy diffe-
rences were below 0.01 kcal/mol.
The liposome mean diameter was measured 
in three fresh samples of the formulation F 
by quasi elastic light dispersion was 124 ± 
32.1 nm with a polydispersity index of 0.09. 
Similar values were obtained after storage 
for 6 months at 4ºC (150.6 ± 48.2 nm with 
a polydispersity index of 0.17).
We prove that the maintenance of a homoge-
neous size during a period of 6 months can 
be related to the presence of the DSPC asso-
ciated with small cholesterol percentage.
We also measured the electrophoretic mobi-
lity and zeta potential, both in fresh and af-
ter 6 months storage at 4ºC samples of lipo-
somes of formulation F with Doppler laser. 
The results obtained confirmed the negative 
charge and showed no statistical significant 
differences before and after aging.
These results are of particular importance 
once they demonstrate the adequacy of the 
formulation for the production of a future 
kit for nuclear medicine studies for visuali-
sation of the lung lymphatic drainage.
In summary, the developed liposomal for-
mulation F demonstrated to have physico-
chemical and radiopharmaceutical proper-
ties that make it a very promising probe for 
molecular imaging studies of lung deep 
lymphatic chains. In addition, the labelled 
vesicles also displayed stability and toxicity 
profiles compatible with their human use 
for the evaluation of pulmonary lymphatic 
drainage in a standard diagnostic nuclear 
medicine environment.
In vivo studies
One of the goals of this work is to develop a 
methodology that allows, with a minimal 
invasion, to study the lung deep lymphatic 
drainage, which can be involved in several 
lung pathologies.
Also, the intention of administered the tra-
cers as aerosols, is an important part of that 
goal. However, this implies that the lipo-
somes that carry the gamma emitting mo-
lecules must reach juxta-alveolar lymphatics 
and the lymphatic capillaries associated to 
the respiratory bronchioles, i.e., the lipo-
somes must reach the respiratory zone of 
the lung.
In general terms we can say that the particle 
deposition with diameters bigger than 1 μm 
occurs before the pulmonary compartment. 
Particles with diameters less than 1 μm are 
deposited in the pulmonary compartment, 
mainly by diffusion. Particles with a pre-
dominate dimension like the bacilli have a 
tendency to follow the aerodynamic flow, 
moving with its long axis parallel to the di-
rection of the movement, which became 
more dependents on its small axis. This fact 
provokes a more peripheral deposition then 
expected54.
As liposomes are sphere-shaped, oppositely 
to the bacilli, they must have diameters less 
then 1 μm, what it is in accordance with the 
dimensions obtained for liposomes of for-
mulation F, when were measured by quasi 
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elastic light dispersion (average diameter = 
124 ± 32.1 nm). With these dimensions, 
the liposomes have capacity to reach the 
pulmonary compartment, as it was con-
firmed by SEM analysis, carried out in rat 
lung, 20 minutes after inhalation of lipo-
somes of formulation F.
Once reached the pulmonary compartment, 
the particle clearance to the juxta-alveolar 
lymphatics and the lymphatic capillaries as-
sociated with the respiratory bronchioles, 
can be carried by several forms8. With the 
developed liposomes, the SEM studies seem 
to prove that they can be phagocyted by al-
veolar macrophages (Fig. 15) or directly 
transferred through the intercellular junc-
tions (Fig. 14) to the lung interstitium.
The indirect lymphoscintigraphic studies, 
carried out in 20 pigs, with liposomes of 
formulation F labelled with 99mTc-HM-
PAO, showed that the alveolar clearance 
was relatively fast. In fact, the effective half-
life at pulmonary level is of 45 minutes.
With this decay time, it is possible, as it 
proves the developed experimental model, 
the evaluation of the thoracic area. In the 20 
pigs studied, the average times for lympha-
tic structures visualisation, after the lipo-
somes inhalation, was of 5 minutes for the 
hilar and interpulmonary drainage chains. 
By this time, the transdiaphragmatic drai-
nage chains are already delineated, being 
individualised approximately at 10 minutes. 
The ganglia of the aortic chain are visible at 
the 20 minutes and those of the renal hilar 
region by the 30 minutes.
We think that the visualization of descending 
transdiaphragmatic lymphatic drainage 
chains, easily after the aerosol inhalation, is 
important information given by this method. 
Simultaneously, the visualization of pelvic lo-
calizations at delayed times allowed us to 
suppose the presence of accessory lymphatic 
drainage chains that can be of great impor-
tance when a tumoral staging is needed.
The abdominal and pelvic localizations, 
namely the ones that correspond to the re-
nal and bladder projection areas, put some 
interpretative problems. In fact, if the in 
vitro liposomes stability allows us to think 
in localization associated to the lymphatic 
drainage, the localizations themselves let us 
to think about in vivo liposomal degrada-
tion. To clarify this possibility, blood sam-
ples were collected at 5 min, 30 min, 1, 2 
and 3 hours and urine samples at 3 hours 
after liposomes inhalation, in a group of 8 
animals, during image acquisition period. 
The counts obtained through a well counter 
showed, after normalisation related to the 
administered activity, considering the 100% 
the maximum of the lung activity.
The irrelevant specific activity found in 
these samples (approximately 10-5 % of the 
administered activity) proves that the lipo-
somes practically do not leak its aqueous 
content. This, being hydrosoluble, would 
pass to the blood, excreted through the kid-
ney to the urine. Having practically no ac-
tivity at blood and urine, the localizations at 
renal and bladder projections area, do not 
represent sanguineous or urinary activity.
This was confirmed by the indirect lym-
phographies with methylene blue, which by 
direct visualization of the lymphatic drain-
age clarified those localizations (Figs. 21, 22 
and 28). Therefore, in the pelvic region we 
can see two blue coloured areas, one in the 
retrovesical region and another in the ab-
dominal wall over the bladder and, in the 
renal projection area and renal hilum, an in-
tense lymphatic network.
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The analysis carried with the ROIs drawing in 
the acquired images, to verify if there was lo-
calizations corresponding to the presence of 
liposome in the systemic circulation through 
venous return as well as corresponding activity 
to the loss of the liposomal aqueous content 
by degradation, also confirmed our results.
Additionally, the localization of the abdomi-
nal lymphatic ganglia was confirmed by indi-
rect lymphoscintigraphy with nanocolloids 
of human albumin labelled with technetium-
99m, a specific tracer to lymphatic drainage 
and lymphatic ganglia. The comparison of 
these images, with those obtained with lipo-
some aerosols allowed us to say that after 1.5 
hours, no significant information is added. 
On account of this, the time required to the 
scintigraphy is relatively short.
To ensure the fiability of the results, data 
was statistically analysed, based on the ac-
tivities detected in the nodes localizations as 
well as on the background activity. The sig-
nal-noise relationship of the lymphatic 
nodes, at the maximum activity timing, 
showed values that fluctuate from 5 times to 
some orders of magnitude, being the statis-
tical errors systematically inside of the ac-
ceptable limits in experimentation.
As conclusion we can affirm that the deve-
loped liposomal formulation F demonstrat-
ed to have physicochemical and radiophar-
maceutical properties that make it a very 
promising probe for molecular imaging 
studies of lung deep lymphatic chains. In ad-
dition, the labelled vesicles also displayed 
stability and toxicity profiles compatible 
with their human use for the evaluation of 
pulmonary lymphatic drainage in a standard 
diagnostic nuclear medicine environment.
In general terms, we can say that when pul-
monary pathology is associated with deep 
lymphatic involvement, its study is possible 
and useful, and the presented method is a 
real possibility. It seems that the visualisa-
tion of the early descending transdiaphrag-
matic drainage chains, adds important in-
formation that can be crucial when an 
accurate tumoral staging is need.
Keeping in mind the stability characteristics 
along the time, these liposomes can be made 
and stored, as a kit, ready to use.
The developed methodology of labelling af-
ter liposomes production, like a cold radio-
pharmaceutical kit ready to radiolabelling, 
facilitates a lot its practical application.
This technology of nanoradioliposomes 
molecularly modulated, with specificity for 
organs or tissues can open new perspectives 
in diagnostic and therapeutic techniques.
In fact, this work showed that is possible to 
produce nanoradioliposomes targeting organs 
or tissues, not only for basic investigation but 
also with diagnostic and/or therapeutic pur-
poses. This assumption is confirmed by the 
versatility induced by this modulation tech-
nique. In the future, their use could maximise 
the drug actions or even potentiate them, 
minimising the collateral effects.
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